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Abstract
Tuberculosis, caused by Mycobacterium tuberculosis, remains a leading infectious disease despite the availability of
chemotherapy and BCG vaccine. The commonly used avirulent M. tuberculosis strain H37Ra was derived from virulent strain
H37 in 1935 but the basis of virulence attenuation has remained obscure despite numerous studies. We determined the
complete genomic sequence of H37Ra ATCC25177 and compared that with its virulent counterpart H37Rv and a clinical
isolate CDC1551. The H37Ra genome is highly similar to that of H37Rv with respect to gene content and order but is 8,445
bp larger as a result of 53 insertions and 21 deletions in H37Ra relative to H37Rv. Variations in repetitive sequences such as
IS6110 and PE/PPE/PE-PGRS family genes are responsible for most of the gross genetic changes. A total of 198 single
nucleotide variations (SNVs) that are different between H37Ra and H37Rv were identified, yet 119 of them are identical
between H37Ra and CDC1551 and 3 are due to H37Rv strain variation, leaving only 76 H37Ra-specific SNVs that affect only
32 genes. The biological impact of missense mutations in protein coding sequences was analyzed in silico while nucleotide
variations in potential promoter regions of several important genes were verified by quantitative RT-PCR. Mutations
affecting transcription factors and/or global metabolic regulations related to in vitro survival under aging stress, and
mutations affecting cell envelope, primary metabolism, in vivo growth as well as variations in the PE/PPE/PE-PGRS family
genes, may underlie the basis of virulence attenuation. These findings have implications not only for improved
understanding of pathogenesis of M. tuberculosis but also for development of new vaccines and new therapeutic agents.
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Introduction
Tuberculosis (TB) remains a leading infectious disease despite
the availability of chemotherapy and the BCG vaccine. Mycobac-
terium tuberculosis, the causative agent of TB, is a highly successful
pathogen that has latently infected one third of the world
population (2 billion people) and causes 9 million new cases and
about 2 million deaths each year worldwide (http://www.who.int/
gtb/). The mechanisms by which M. tuberculosis causes disease have
remained largely unknown until the improvement made recently
via the application of modern molecular genetic tools, including
genomic sequencing of the common lab virulent reference strain
H37Rv [1], the clinical isolate CDC1551 [2], M. bovis [3] and M.
bovis BCG [4] strains. However, comparative genomic analysis of
paired virulent M. tuberculosis H37Rv strain versus the avirulent
H37Ra strain has been lacking.
Historically, M. tuberculosis H37Ra is the avirulent counterpart of
virulent strain H37Rv and both strains are derived from their
virulent parent strain H37, which was originally isolated from a 19
year-old male patient with chronic pulmonary tuberculosis by
Edward R. Baldwin in 1905 [5]. In order to obtain stable avirulent
derivatives of H37, in 1935, William Steenken carried out a
dissociation study based on aging of H37 bacilli on solid egg media
[6]. The parental virulent H37 was inoculated onto solid egg
media at pH 6.2. The resulting culture was allowed to age for 3–4
months at 37uC. By the end of the extended incubation, the
original dry, discrete colonies lysed and transformed into a
confluent viscous mass. In the midst of the viscous mass, secondary
growth with different colony morphology emerged. The new
growth, when picked and cultured on fresh media, produced no
disease in guinea pigs [6,7] and was designated H37Ra (‘‘a’’ for
avirulent). The virulent counterpart (i.e., H37 but with rough
colony morphology) [5] was named H37Rv (‘‘v’’ for virulent) and
the original H37 was discontinued. Both H37Ra and H37Rv
strains were maintained at Trudeau Institute, Saranac Lake, New
York, for many years and were later deposited in the American
Type Culture Collection (ATCC). H37Ra and its virulent
counterpart H37Rv have been widely used as reference strains
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since 1940s and H37Ra is also used as an adjuvant to boost
immunogenicity during immunization.
H37Ra has several characteristics that are different from its
virulent sister strain H37Rv, including a raised colony morphology
[6], loss of cord formation [8], loss of neutral red dye binding [9],
decreased survival under anaerobic conditions [10,11] or inside
the macrophages [12], impaired ability to disrupt phagosomal
membranes [13], and loss of virulence in guinea pigs [6,7,14] and
mice [15,16]. The distinguishing characteristics of H37Ra and
H37Rv are maintained indefinitely on subculture, suggesting that
the two strains differ genetically. Despite numerous biochemical
and genetic studies in the past 70 years [9,11,17–26], the
molecular basis for the attenuation of virulence in H37Ra has
remained obscure.
In this study, we determined the whole genome sequence of the
M. tuberculosis H37Ra strain from the American Type Culture
Collection (ATCC25177). Comparative genomic analysis of
H37Ra with its recently sequenced virulent counterpart H37Rv
not only provides important insights into the basis of attenuation of
virulence in H37Ra but also improves our understanding of
virulence and pathogenesis of M. tuberculosis.
Results
Genomic Features of M. tuberculosis H37Ra and Its Global
Comparison with the Pathogenic Counterpart H37Rv and
CDC1551
M. tuberculosis H37Ra ATCC25177 contains a single circular
chromosome of 4,419,977 bp with an average G+C content of
65.61% (GenBank accession number CP000611). A total of 4034
protein-coding sequences (CDS) are identified in the H37Ra
genome with an average length of 1000 bp, representing 90.1% of
the genome (Figure 1). Comparison with the H37Rv genome
(GenBank accession AL123456) revealed a highly conserved gene
content and order between these two strains. The base numbering
start point of the H37Ra genome was chosen at the first base of the
dnaA gene as in H37Rv, coinciding with the replication origin (oriC,
Figure 1). The genome size of H37Ra is 8,445 bp larger than that
of H37Rv (4,411,532 bp), as a result of 53 insertions and 21
Figure 1. Atlas of the Chromosome of M. tuberculosis H37Ra ATCC25177 and its Comparison with M. tuberculosis H37Rv. Moving
inside, each concentric circle represents genomic data for M. tuberculosis H37Ra and its comparison with M. tuberculosis H37Rv. The outer circle
illustrates predicted coding sequences on the plus and minus strands, respectively, colored by functional categories according to COG classification.
The 2
nd circle represents location of nucleotide substitution in coding regions (purple for synonymous substitutions; green for nonsynonymous
substitutions) and noncoding regions (red), respectively. The 3
rd circle displays loci of insertions in H37Ra, distinguished by coding regions (red) and
noncoding regions (purple). The 4
th circle shows loci of deletions in H37Ra, distinguished by coding regions (red) and noncoding regions (purple).
The 5
th circle presents H37Ra specific genes compared with H37Rv and CDC151 genes, red for CDSs with variations and green for genes with
promoter variations. The 6
th circle (innermost) represents GC skew (G2C)/(G+C) calculated using a 5 kb window.
doi:10.1371/journal.pone.0002375.g001
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relative to H37Rv (see Table S1, S2 with notes). Besides these
indels, 198 single nucleotide variations (SNVs) are identified
between H37Ra and H37Rv (Table S3).
When all of the 272 genetic variations in H37Ra (including 198
SNVs, 53 insertions and 21 deletions) were compared with their
corresponding loci in the clinical isolate CDC1551, it is interesting to
note that the similarity between H37Ra and CDC1551 is higher than
that between H37Ra and H37Rv (Table 1). Between H37Ra and
CDC1551, 119 SNVs, 14 insertions and 5 deletions are the same,
and thus, we designate these 138 variations as ‘‘H37Rv-specific’’.
Since H37Ra and H37Rv both evolved from the same parental
strain H37, it is unlikely that H37Ra could accumulate so many
variations identical to CDC1551. Thus we re-sequenced the
corresponding H37Rv genomic regions covering the 138
‘‘H37Rv-specific’’ variation loci. Surprisingly, among the 85
successfully sequenced sites (including 72 SNV loci, 10 insertion
loci and 3 deletion loci, while the unsuccessfully sequenced sites
were mainly in the PE/PPE/PE-PGRS regions), only 3 SNV loci,
2 insertion loci and 1 deletion loci are the same as the published
H37Rv genomic sequence, while the remaining 79 sites are
identical to those of H37Ra and CDC1551 (Table S4).
The 6 real ‘‘H37Rv-specific’’ variations (i.e., those that are
different from both H37Ra and CDC1551) are likely acquired
during long-term repeated in vitro cultivation of H37Rv over the
years but unrelated to the virulence property. Therefore, when all
the 138 ‘‘H37Rv-specific’’ variations are excluded from the 272
genetic variations in H37Ra, we have only 134 total genetic
variations that are ‘‘H37Ra-specific’’, including 79 SNVs, 39
insertions and 16 deletions that are different from H37Rv or
CDC1551. To ensure that these 134 ‘‘H37Ra-specific’’ variations
are indeed unique to H37Ra and not due to possible sequencing
errors of H37Rv sequence, we again re-sequenced these 134
‘‘H37Ra-specific’’ variation loci using our strainof H37Rv (obtained
from Trudeau Institute but maintained in mice, see Methods). We
found 3 of the 79 SNVs and 1 ofthe 16 deletions to be the same as in
H37Ra. Therefore, when these 4 sites together with all of the 138
‘‘H37Rv-specific’’ variations are excluded from the total of 272
genetic variations that differ from H37Ra and H37Rv, only 130
genuine ‘‘H37Ra-specific’’ genetic variations, including 76 ‘‘H37Ra-
specific’’ SNVs, 39 ‘‘H37Ra-specific’’ insertions and 15 ‘‘H37Ra-
specific’’ deletions were further analyzed for their potential impacts
on H37Ra phenotypes (Table S4).
Among the 76 SNVs, 2 are synonymous mutations, 8 are
located in intergenic regions and predicted to have no effect on
promoters. The remaining 66 SNVs might affect either promoter
regions or CDSs of merely 32 genes, i.e., 8 might affect the
promoter of 12 genes (in some cases 1 SNV site is located in the
probable promoter region of 2 divergently transcribed genes), and
58 affect the CDSs of 20 genes. Among the 39 ‘‘H37Ra-specific’’
insertions, 14 are located in the intergenic regions that might have
no effect on gene promoters. For the remaining 25 insertions, 23
affect 19 CDSs while the other 2 might affect probable promoters
of 2 genes. A total of 15 ‘‘H37Ra-specific’’ deletions might affect
12 genes, of which, 5 might affect probable gene promoters and 10
affect the CDSs. In sum, a total of 57 genes in H37Ra are likely
affected by genetic variations and will be the focus of our
functional analysis (Table 2).
To determine the impact of the sequence variations within the
probable promoter regions of H37Ra, we performed real-time
quantitative RT-PCR (qRT-PCR) to compare the levels of
expression for several important candidate genes (sigC, nrdH,
phoH2, pabB, lpdA) in H37Ra vs H37Rv both in culture and in
macrophages. Interestingly, their expression levels were all
increased in vitro but decreased in macrophages in H37Ra
compared with H37Rv (p,0.05) (Figure 2).
IS6110 Related Genetic Variations between H37Ra and
H37Rv and in Comparison to CDC1551
The H37Ra genome contain 32 complete and 10 disrupted IS
elements (Table S5), almost identical to that of H37Rv except for
slight differences in IS6110. In addition, only a limited number of
Long Sequence Polymorphisms (LSPs, i.e., indels greater than 10
bp) [2] are identified between H37Ra and H37Rv and all of them
are either IS6110 related or in the PE/PPE/PE-PGRS family.
There are 17 complete copies of IS6110 in H37Ra, but 16 copies
in H37Rv. The difference in IS6110 copy number between
H37Ra and H37Rv is due to two complete ‘‘H37Ra-specific’’
IS6110 insertions, located at 14 kb [22] and 1990 kb away [27]
from oriC, respectively (Figure 3A), in addition to one complete
IS6110 deletion (1358 bp, containing Rv3184 and Rv3185) in
H37Ra located in a region which seems to be a hot spot for
IS6110 insertion, where H37Ra has only one but H37Rv has two
copies of IS6110 (Figure 3B). The absence of one copy of IS6110
in H37Ra is unlikely to result from IS6110 excision or IS6110-
related recombination but rather due to acquisition of the IS6110
in H37Rv, since the identical direct repeats (DRs) found flanking
the IS6110 at this location in H37Ra do not support the possibility
of a recombination between two neighboring IS elements causing
deletion of one copy of IS6110 in H37Ra [28,29].
There are five H37Rv related deletion (RvD) loci defined based
on the genomic deletions identified in M. tuberculosis H37Rv
compared to M. bovis and M. bovis BCG [27], and four of them are
associated with IS6110 [22]. Among these RvD loci, only the
RvD2 of H37Ra is different from that of H37Rv, where an 8166
bp insertion is located between the 59 proximal of plcD gene and
the adjacent IS6110 (Figure 3C). This fragment contains 6
complete CDSs with 2 of them (MRA_1767, MRA_1768)
belonging to a complete IS6110 located at 1990 kb from oriC.
Further comparison with CDC1551 suggested that this fragment
once existed in H37Rv, but was subsequently deleted after an
IS6110-mediated recombination (Figure 3C). Assuming that
CDC1551 retains more genomic characteristics of the common
ancestor for H37Ra, H37Rv and CDC1551, an IS6110 (1990795-
1989441) is inserted between the 476
th and the 477
th bp of the plcD
gene thus causing a 59 truncation in the plcD gene of H37Ra (the
59 part of plcD gene formed a new CDS, MRA_1768A). However,






variations Corresponding loci in CDC1551
Same as in H37Ra*
(H37Rv-specific)
Same as in H37Rv
(H37Ra-specific)
Total Number 272 138 88
SNVs 198 119 63
Transitions 102 69 26
Transversions 96 50 37
Insertions ($1bp) 53 14 15
Deletions ($1bp) 21 5 10
*Detailed information about variations that are the same between H37Ra and
CDC1551 can be found in Tables S1, S2 and S3.
doi:10.1371/journal.pone.0002375.t001
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H37Ra gene H37Ra gene product Variation H37Rv Locus H37Rv gene product
MRA_0011 IS6110 transposase insertion Rv0010c up membrane protein
MRA_0012 IS6110 hypothetical protein insertion Rv0010c up membrane protein
MRA_0040 conserved integral membrane protein SNV Rv0037c integral membrane protein
MRA_0042 up conserved transmembrane protein SNV Rv0039c up transmembrane protein
MRA_0105 peptide synthetase SNV Rv0101 peptide syntherase Nrp
MRA_0131 PE-PGRS SNV Rv0124 PE-PGRS
MRA_0197 dihydroxy-acid dehydratase SNV Rv0189c dihydroxy-acid dehydratase
MRA_0288 PE-PGRS family protein insertion+deletion+SNV Rv0279c PE-PGRS
MRA_0391 up conserved secreted protein deletion Rv0383c up Conserved secreted protein
MRA_0585 PE-PGRS SNV Rv0578c PE-PGRS
MRA_0646 hypothetical protein deletion Rv0635 hypothetical protein
MRA_0648 hypothetical protein insertion Rv0637 hypothetical protein
MRA_0767 two component system response transcriptional
positive regulator PhoP
SNV Rv0757 PhoP
MRA_0885 PPE family protein insertion Rv0878c PPE
MRA_0887 marr-family transcriptional regulatory protein SNV Rv0880 Transcriptional regulatory protein(MarR)
MRA_0984 PE-PGRS SNV Rv0977 PE-PGRS
MRA_1014 up para-aminobenzoate synthase component I SNV Rv1005c up para-aminobenzoate synthase component I
MRA_1015 up hypothetical protein SNV Rv1006 up hypothetical protein
MRA_1029 hypothetical protein SNV Rv1021 hypothetical protein
MRA_1078 PE-PGRS family protein SNV Rv1068c PE-PGRS
MRA_1102 PE-PGRS family protein insertion+SNV Rv1091 PE-PGRS
MRA_1106 up PhoH-like protein PhoH2 SNV Rv1095 up PhoH2
MRA_1205A PPE deletion Rv1196 PPE
MRA_1395 up PE SNV Rv1386 up PE
MRA_1459 PE-PGRS insertion+SNV Rv1450c PE-PGRS
MRA_1766 putative phospholipase C 4 PlcD insertion Rv1755c up PlcD
MRA_1767 IS6110 transposase insertion Rv1755c up PlcD
MRA_1768 IS6110 hypothetical protein insertion Rv1755c up PlcD
MRA_1768A hypothetical protein insertion Rv1755c up PlcD
MRA_1772 PE-PGRS insertion Rv1759c PE-PGRS
MRA_1779 disrupted IS6110 transposase insertion Rv1765c hypothetical protein
MRA_1815 up PPE SNV Rv1802 up PPE
MRA_1940 hypothetical protein deletion Rv1929c hypothetical protein
MRA_2063 polyketide synthase Pks12 SNV Rv2048c polyketide synthase Pks12
MRA_2082 up beta-lactamase SNV Rv2068c up Beta-lactamase BlaC
MRA_2083 up RNA polymerase sigma-70 factor SNV Rv2069 up RNA polymerase sigma-70 factor
MRA_2113 PE-PGRS insertion intergenic
MRA_2376 PPE insertion Rv2352c up PPE
MRA_2420 PE-PGRS SNV Rv2396 PE-PGRS
MRA_2447 up nicotinic acid mononucleotide adenyltransferase SNV Rv2421c up nicotinic acid mononucleotide adenyltransferase
MRA_2678 IS6110 transposase SNV Rv2649 IS6110 transposase
MRA_2759 up alanine and arginine rich protein SNV Rv2733c alanine and arginine rich protein
MRA_2760 up hypothetical protein SNV Rv2734 hypothetical protein
MRA_2849 up hypothetical protein insertion Rv2825c up hypothetical protein
MRA_3085 up putative glutaredoxin NrdH deletion Rv3053c up putative glutaredoxin NrdH
MRA_3225 hypothetical protein deletion intergenic
MRA_3344 up dihydrolipoamide dehydrogenase LpdA insertion Rv3303c up dihydrolipoamide dehydrogenase
MRA_3384 PPE deletion Rv3343c PPE
MRA_3391 PPE insertion Rv3350c PPE
MRA_3428 PE-PGRS deletion Rv3388 PE-PGRS
Loss of Virulence in H37Ra
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th and the 697
th
bp of the plcD gene and a subsequent homologous recombination
between this IS6110 and the adjacent IS6110 located at the 59 end
of the cut1 gene caused a deletion of an 8 kb fragment in H37Rv.
This proposition is supported by analyzing the DRs flanking these
IS6110 elements. The ‘GAG’ adjacent to the right end of IS6110
in H37Rv is similar to the DRs of IS6110 next to the cut1 gene in
H37Ra and CDC1551, while the 3 bases adjacent to the left end
of H37Rv IS6110 is ‘AAG’, similar to the IS6110 insertion site of
plcD gene. Therefore, the two pieces of the once co-existing IS6110
elements with DRs of ‘AAG’ and ‘GAG’ likely had undergone a
recombination that generated one IS6110 element carrying one
DR of each parent in H37Rv.
Corresponding to the previously described RvD3 locus in
H37Rv [22,30], an IS6110 remnant of 247 bp is found adjacent to
this region in H37Ra, joining with a complete IS6110 (Figure 3D).
Referring to the corresponding region in CDC1551 and the
sequence of DRs, one might assume that two IS6110 elements
were once inserted in this region of H37 and in the process of
evolving, recombination between these two IS elements caused the
deletion of RvD3 in H37Rv and H37Ra. Subsequent recombi-
nation in H37Ra underwent an incomplete exchange, leaving the
247 bp IS6110 remnant as observed.
A 2064 bp insertion present in both H37Ra and CDC1551 but
deleted from H37Rv is designated as RvD6 (Figure 3E). This
fragment, which contains two genes (MRA_2374, MRA_2375)
encoding esat-6 like proteins and a gene encoding a PPE family
protein (MRA_2376), is located at 1 bp upstream of the start
codon of MRA_2373 (Rv2352c). The MRA_2376 is identical to
MRA_2373, and the same gene duplication is observed in
CDC1551 (MT2419 and MT2422). However, only one homol-
ogous gene (Rv2352c) is found in H37Rv. It is most likely that a
recombination occurred between the two precursors of Rv2352c
and induced the 2064 bp deletion in H37Rv.
Mutations Affecting Transcription Factors and Global
Regulations
The high degree of similarity in the genomic content and the
apparently disparate phenotypes between H37Ra and H37Rv
indicate that mutations in transcription factors and genes related
to global regulations might account for its unique characteristic of
growth and/or attenuated virulence of H37Ra. In fact, only
limited mutations are found in this category.
A transversion (A-T) is identified in H37Ra, in the predicted
promoter region, 51 bp upstream of the start codon of sigC
(MRA_2083/Rv2069), which encodes the extracellular function
(ECF) subfamily sigma factor [31] (Table S6). Our qRT-PCR result
indicated that the transcription levels of sigC in H37Ra were up-
regulated compared to H37Rv in log phase cultures, but the
transcription level of sigC in H37Ra was nearly 4 times lower than
H37Rv in macrophages (Figure 2). SigC is known to regulate the
expression of at least 38 genes involved in a broad range of cellular
processes and disruption of sigC resulted in a significant virulence
attenuation in mice [31] and guinea pigs [32]. Therefore, decreased
expressionofsigC inH37Rainmacrophagesmightimpacttheglobal
gene regulation related to its attenuation of virulence.
Hyperphosphorylated guanine [(p)ppGpp], an important cellu-
lar second message controlling gene expression in stringent
response, is required for long-term survival of M. tuberculosis under
starvation and in vivo persistence [33,34]. In E. coli, MazG regulates
the MazEF-mediated stringent response by depletion of ppGpp
[35]. Compared to the counterpart Rv1021 in H37Rv, the H37Ra
MRA_1029 (MazG) has a missense mutation resulting in an
Figure 2. Transcription Analysis of Selected Genes with
Promoter Mutations in H37Ra Compared to H37Rv in culture
and in macrophages. The in vitro cultured M. tuberculosis H37Ra and
H37Rv were grown to log phase. The bacterial cells in macrophages
were harvested 24 hours after infection. Mycobacterial RNA was
isolated and 16 S rRNA gene and sigA were used as internal controls
for normalization of the transcriptional analysis for in vitro and
macrophage derived mycobacteria, respectively. The transcription
levels of the selected genes (lpdA, pabB, phoH2, sigC and nrdH) were
determined by qRT-PCR as described in the Methods. Error bars were
given as standard deviations (SDs) of the means. E phase: exponential
(log) phase. Mw: macrophage. The RT-PCR data were repeated at least
three times. ** indicates p value ,0.05.
doi:10.1371/journal.pone.0002375.g002
Table 2. cont.
H37Ra gene H37Ra gene product Variation H37Rv Locus H37Rv gene product
MRA_3428A hypothetical protein insertion+SNV Rv3389c dehydrogenase
MRA_3547 PE-PGRS SNV Rv3507 PE-PGRS
MRA_3548 PE-PGRS insertion Rv3508 PE-PGRS
MRA_3553 PE-PGRS insertion+deletion+SNV Rv3514 PE-PGRS
MRA_3635 PE-PGRS deletion Rv3595c PE-PGRS
MRA_3649 up cell division protein FtsH deletion+SNV Rv3610c up FtsH
MRA_3918 alanine and proline rich protein SNV Rv3879c arginine and proline rich protein
Synonymous SNV in coding region
MRA_2218 carbohydrate kinase CbhK SNV Rv2202c carbohydrate kinase CbhK
MRA_3062 hypothetical protein SNV Rv3031 hypothetical protein
doi:10.1371/journal.pone.0002375.t002
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218PAL-
motif of the MazG (Figure 4A). This motif is within the predicted
H1 a-helix, conserved across the MazG enzyme family, and
together with three other helices, they comprise the active site of
triphosphate pyrophosphatases [36]. Significant charge alteration
in this critical motif might affect the enzyme activity and in turn
alter the stringent response.
Figure 4. Multiple Sequence Alignment of MazG (A) and the C-
Terminal Effector Domains of PhoP (B). The amino acid sequences
used are from M. tuberculosis H37Rv (Rv), H37Ra (Ra), CDC1551(CDC), M.
bovis (MB), M. bovis BCG (BCG), M. avium (MA), M. smegmatis (MS),
Escherichia coli (EC) and Bacillus subtilis (BS). The numbers refer to the
amino acid residues of MazG and PhoP. The key secondary structure
element (a3-helix) of PhoP is indicated above the sequence. The site of
substitution is indicated by an asterisk under the sequence.
doi:10.1371/journal.pone.0002375.g004
Figure 3. Schematic Diagram of IS6110-Mediated Genetic
Variations Detected among H37Ra, H37Rv And CDC1551. A.
IS6110 distributions in the chromosomes of known M. tuberculosis
complex strains. Blue arrow represents IS6110 elements shared by more
than one strain. Red arrow indicates IS6110 elements specifically
detected only in one strain. The direction of arrow indicates the
transcription orientation of the transposase genes. The numbers above
the arrows indicate the location (kb) of IS6110 in the strains relative to
the oriC in clockwise direction. B. Schematic diagram of a hot spot
region for IS6110 insertion. ‘ATT’, ‘CGA’ are the DRs flanking each IS6110,
the same DRs on both sides of one IS6110 indicate that no IS6110
recombination had occurred here. In CDC1551, no IS6110 is found in
this region but instead, a gene MT3275.1 is present, which is disrupted
by IS6110 insertion(s) in H37Ra and H37Rv. C. Schematic diagram of the
plcD-cut1 region (RvD2) in H37Ra, H37Rv and CDC1551. The H37Ra
CDSs are predicted to encode hypothetical proteins (MRA_1768A, and
MRA_1768B), encoding a putative sulfite oxidase (MRA_1768C) and a
putative transmembrane transport protein MmpL14 (MRA_1768D).
‘GAG’, ‘TAG’, ‘AAG’ are the DRs flanking the IS element. The coding
sequences of MT1800, MT1801 and MT1802 of CDC1551 are identical to
that of MRA_1768B, MRA_1768C and mmpL14 gene, respectively. D.
Schematic diagram of the H37Ra MRA_1776-MRA_1780 region,with
IS6110 related 247 bp insertion (MRA_1779). Corresponding regions in
H37Rv and CDC1551 are shown for comparison. The MT1812, MT1813
and 39 end of MT1814 of CDC1551 correspond to the RvD3 region of
H37Rv. The 247 bp remnant and its probable original counterpart in
H37Rv are shaded. Referring to CDC1551 and the DRs, it might be
inferred that two IS6110 elements were once inserted in the RvD3
region in the process of evolving H37Ra and H37Rv. Subsequent
recombination between these two IS elements caused deletion of RvD3
in H37Ra and H37Rv. The recombination in H37Ra underwent an
incomplete exchange, leaving the remnant observed. E. Schematic
diagram of the 2064 bp insertion region containing 2 esat-6 like protein
genes (MRA_2374, MRA_2375) and a PPE family protein gene
(MRA_2376). A neighboring IS6110 insertion is shown which might be
H37-specific. H37Ra and H37Rv share the same IS6110 insertion which
disrupted the MT2423, generating a new gene, MRA_2377 (Rv2353c).
doi:10.1371/journal.pone.0002375.g003
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factor in M. tuberculosis [37] and encodes a transcription activator
in response to the sensor kinase, PhoR, located at the cell surface.
This two-component regulatory system controls the expression of
virulence genes including genes involved in synthesis of cell wall
lipids [38,39]. The H37Ra PhoP has a single base substitution
resulting in highly conserved Ser219 replaced by Leu, which is
located in the DNA binding a3 helix region of PhoP (Figure 4B).
This mutation could impair the DNA binding of and transcription
activation by PhoP and may be partly related to attenuation of
virulence in H37Ra.
Mutations Affecting Genes Directly Related to
Metabolism and in vivo Growth
Several variations, mostly in the probable promoter regions of
genes related to primary metabolism (Table S6), might impair the
proper transcription tested by the above qRT-PCR experiments
and alter the capability of the bacilli to survive in vitro and/or in
vivo. Both pabB (MRA_1014/Rv1005c) and nrdH (MRA_3085/
Rv3053c) genes were poorly expressed in H37Ra at 24h post-
infection inside macrophages, but their in vitro expression in culture
was up-regulated (Figure 2). A T-A transversion at -66 bp of the
translational start codon of pabB identified in H37Ra (Table S6)
might affect this potential promoter region causing alteration of
expression. The pabB gene encodes para-aminobenzoate synthetase
component-I involved in the biosynthesis of p-aminobenzoate
(PABA), a precursor of folate biosynthesis. Mutation in pabB was
shown to cause attenuation of virulence in Burkholderia pseudomallei
[40]. The nrdH gene encoding glutaredoxin had a 14 bp deletion
in its potential promoter region compared to that of Rv3053c in
H37Rv, where it forms a duplicated tandem repeat (Figure S1).
The nrdH gene is likely located in an operon with nrdI
(MRA_3084), nrdE (MRA_3083) and perhaps, with nrdF2
(MRA_3080) as well. Due to the important role of the NrdEF2
complex in chromosome duplication and DNA repair [41], the
alteration in expression of this nrdHIEF2 operon might impact exit
from dormancy or survival in vivo.
The ilvD (MRA_0197, Rv0189c) gene encoding dihydroxy-acid
dehydratase, an essential enzyme for branch chain amino acid and
pantothenate (coenzyme A) biosynthesis, has a highly conserved
Val284 (GTA) being substituted by Gly284 (GGA) in H37Ra.
Since this variation is not located in any specific domains and
there is no branch chain amino acid related phenotype for H37Ra
[42], the biological significance of this mutation remains to be
determined.
In the intergenic region between lpdA (Rv3303c/MRA_3344)
and Rv3304 (MRA_3345), a 58 bp tandem repeat unit is repeated
twice in H37Rv and CDC1551, but three times in H37Ra (Figure
S1). The additional repeat unit in H37Ra might influence the
expression of lpdA and its downstream gene glpD2 as we found a
hairpin structure (CACGCCGC TGCGCGGCGTG) within this
sequence, which implies a potential binding site for regulatory
proteins. Downstream of the lpdA-glpD2 operon, there is a cluster
of genes, phoY1, MRA_3341 (Rv3300c), atsB and lpqC, which
might be affected by the 58 bp repeat if they were co-transcribed
with the lpdA-glpD2 operon. Within the potential promoter regions
of lpdA-glpD2 operon and the downstream phoY1, each has a SigF
binding site, GGATTG-N16-GGGTAT for phoY1 and GGTTC-
N16-GGGTGC for lpdA (Figure S1). The phoY1 encodes a
probable transcriptional regulatory protein homologous to the
PhoU protein involved in regulation of phosphate uptake and
persister formation in E. coli [43]. Our qRT-PCR experiment
indicated that the H37Ra lpdA transcript was hardly detected at 24
hr after macrophage infection, whereas in H37Rv, it was up-
regulated significantly compared to in vitro control (Figure 2).
A G-A transition is identified in the probable promoter region of
another gene involved in phosphate metabolism, phoH2
(MRA_1106/Rv1095). This gene encodes a putative ATPase
involved in phospholipid metabolism and RNA modification [44].
This promoter region mutation caused higher level of expression
of phoH2 in vitro but lower expression in macrophages in H37Ra
than H37Rv (Figure 2).
FtsH is an ATP-dependent membrane bound Zn metallopro-
tease involved in degradation of short-lived regulatory proteins
such as heat shock
32s in the cytosol and unassembled proteins in
the membrane [45]. A 106 bp deletion at 251 bp and a C to T
transversion at 265 bp of the start codon of ftsH (MRA_3649/
Rv3610c) might affect the expression of this gene in H37Ra.
Mutations Altering Cell Envelope and Genes Encoding
Secreted Proteins
Cell envelope proteins, cell wall associated polyketide lipids and
secreted proteins are involved in virulence and host cell interaction
and immune responses [38,39,46]. The genome of M. tuberculosis
contains a significant number of genes (pks) devoted to polyketide
synthesis [1]. Two of them are mutated in H37Ra compared to
H37Rv.
The pks12 (MRA_2063/Rv2048c) is involved in dimycocerosyl
phthiocerol synthesis and the disruption of this gene in H37Rv
caused high degree of attenuation of virulence in mice [47].
Missense mutations TCA-TTA and CCA-GCA in MRA_2063
compared to Rv2048c cause S3004L and P1056A substitutions,
respectively. The latter is in the conserved motif -
1055WPP- within
the linker peptide connecting two domains of acyl transferase and
dehydratase, and is very likely to be deleterious.
The nrp (MRA_0105/Rv0101) gene encodes a non-ribosomal
peptide synthetase involved in polyketide synthesis [48]. The
H37Ra nrp gene has a nonsense mutation at its N-terminus, where
the
93Trp codon TGG is replaced by a stop codon TAG(*),
causing a large truncation of 2420 amino acids at the C-terminus,
which is expected to disrupt the protein function and affect the
synthesis of PDIM.
In H37Ra, the MRA_0040 has a G177D mutation in the
putative transmembrane region leading to loss of two transmem-
brane-helices in Rv0037 of H37Rv. Sequence analysis revealed
that this protein belongs to the major facilitator superfamily (MFS)
involved in transporting small solutes in response to chemiosmotic
ion gradients. Furthermore, a 55 bp deletion is identified at the
266 bp from the start codon of H37Ra MRA_0391 relative to
H37Rv Rv0383c (Table S6). Although it probably encodes a
conserved secreted protein, its biological function is unknown.
Alterations in the PE/PPE/PE-PGRS Family Proteins
We found 35 PE/PPE/PE-PGRS family members that differ
between H37Ra and H37Rv resulting from SNVs and indels
(Table S7). MRA_1772 has a 1 bp insertion which induced a
premature termination relative to its H37Rv ortholog Rv1759c
encoding a fibronectin binding PE-PGRS family protein [49],
causing it to be 2398 bp shorter than the original stop codon.
MRA_3407 has an in-frame insertion of 3 amino acids at the C-
terminus relative to its ortholog Rv3367 encoding the
PE_PGRS51 protein in H37Rv. These H37Rv ortholog proteins
are recognized by antibodies from TB patients [50].
MRA_0754 has five amino acid alterations in the PGRS domain
compared to its ortholog Rv0746, which was induced during
infection [51]. MRA_1205a has a 1 bp deletion at the 922
th base,
causing frameshift and premature termination at the C-terminus in
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previously been shown to induce gamma interferon production in
infected or BCG-vaccinated calves [52]. MRA_3384, encoding a
PPE family protein, lacks 576 amino acids in the C terminus
compared to its ortholog Rv3343c due to a 1728 bp deletion.
Several PE/PPE/PE-PGRS genes seem to be preferential ‘‘hot
spots’’ for mutations, including MRA_0288 (Rv0279), MRA_0395
(Rv0388c), MRA_0754 (Rv0746), MRA_3548 (Rv3508),
MRA_3553 (Rv3514) (Table S7). MRA_3553 is a highly variable
gene and has 25 SNVs (altering 21 amino acids), 2 deletions of 240
bp and 603 bp and one insertion of 9 bp relative to its ortholog
Rv3514. MRA_3548 is 1068 bp shorter than its ortholog Rv3508
due to a 402 bp insertion causing premature termination and 5
SNVs and 7 insertions. Notably, these two genes show extensive
variations when compared to strain CDC1551 and other M.
tuberculosis strains.
Discussion
Despite numerous studies in the past several decades aimed at
elucidating the mechanisms of virulence attenuation in H37Ra,
the genetic basis for the attenuation has remained largely
unknown. In this study, we determined the whole genome
sequence of the attenuated M. tuberculosis strain H37Ra, performed
comparative genomic analysis of H37Ra against its virulent
counterpart H37Rv, and studied their genetic variations in
reference to the clinical isolate CDC1551 genome sequence.
These analyses provide accurate genomic information regarding
the genetic differences between H37Ra and H37Rv, which are
useful for better understanding of the pathogenesis of M. tuberculosis
and basis for virulence attenuation in H37Ra.
Our analysis indicates that IS6110 related indels and associated
LSPs (e.g., RvD6) among H37Ra, H37Rv and CDC1551, may serve
as effective molecular markers to trace their phylogenetic relation-
ship (Figure 5). These markers not only confirmed that CDC1551 is
closelyrelatedtoH37,thedirectancestorofH37RvandH37Ra,but
also indicated that H37Ra might retain more characteristic genetic
features of H37 than H37Rv. The H37Rv specific RvD2 and RvD6
most probably occurred after H37Ra and H37Rv diverged from
H37, while RvD1, RvD3, RvD4 and RvD5 may have occurred
before H37 was evolved or H37 and CDC1551 diverged.
To exclude the mutations accumulated after the original
isolation of H37Ra that are not involved in virulence attenuation,
we freshly ordered the ATCC H37Ra strain ATCC21577
specifically for the genome sequencing in this study. H37Ra
ATCC21577 was deposited in 1960s [16] and has not undergone
significant genetic variations due to lack of subculture. The use of
ATCC21577 H37Ra also minimizes undesired genetic changes
unrelated to its original mutations involved in virulence attenu-
ation, which is endorsed by the finding that only 272 genetic
variations were identified between H37Ra and H37Rv, a relatively
small number of sequence differences compared to 736 SNVs
identified between the attenuated strain BCG Pasteur and M. bovis
AF2122/97 [4]. Through referring the variations to strain
CDC1551 and re-sequencing efforts, we further excluded 138
H37Rv-specific variations that are unlikely to be important for
virulence and focused our analysis on only 66 SNVs, 25 insertions
and 15 deletions that are specific between H37Ra and H37Rv and
may affect CDSs or putative promoters (Table 2). It is surprising
that H37Rv has so many (138 out of 272) SNVs that are different
from H37Ra and CDC1551. Several explanations are possible.
First, the H37Rv strain used for the primary sequencing [1] had
probably accumulated various mutations during repeated in vitro
passages. Second, sequence assembly from different H37Rv
libraries (cosmid and plasmid libraries) constructed at different
times over several years from different batches of H37Rv in the
Figure 5. A Proposed Phylogenetic Relationship of H37Ra, H37Rv, H37, and the Closely Related Clinical Isolate CDC1551. The
process of strain evolution as well as major phenotypes and related genotypes are illustrated in the text. The origination of H37Rv and H37Ra is
described according to the literature [69]. Multiple appearances of both H37Ra and H37Rv represent their possible repeated in vitro passage, which
may cause subsequent genetic variations.
doi:10.1371/journal.pone.0002375.g005
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discrepancy. In addition, possible sequencing errors in the original
H37Rv genome sequence may also be involved.
Through a process of aging for 3–4 months, William Steenken
caused the dissociation of avirulent strain from H37 and other
fresh clinical isolates [6,7]. The multiple phenotypic alterations of
H37Ra [6,8–13] and the failure to fully restore the virulence of
H37Ra by complementation with a cosmid library of H37Rv [18]
suggest that H37Ra must have multiple mutations underlying its
attenuation of virulence. Unlike BCG where multiple large
chromosomal deletions underlie its virulence attenuation [19,55],
our whole genome sequencing analysis indicated that H37Ra has
no gross deletions but instead has about 8 kb more DNA than
H37Rv. This finding explains why the previous genome
subtractive hybridization that led to identification of large
deletions in BCG has failed to identify any deletion in H37Ra
compared with H37Rv [19].
Our comparative genomic studies provided, for the first time, a
molecular roadmap that allows us to address the basis of virulence
attenuation and the multiple phenotypic changes of H37Ra.
Although multiple mutations in noncontiguous chromosomal loci
of H37Ra collectively lead to multiple phenotypic changes
including virulence attenuation, it is likely that one or two initial
mutations affecting global metabolic regulation might provide
some advantage for in vitro survival under the conditions of aging
and cell lysis (Figure 5). The missense mutations affecting MazG
and/or PhoP in H37Ra are likely the candidates for the proposed
primary alterations.
Although the impact of the mazG missense mutation (A219E) in
H37Ra is yet to be determined, it may be inferred from the
regulatory role of MazG upon the MazEF mediated bacteriostasis
via depletion of ppGpp as established in E. coli [35]. There are at
least 7 mazF genes in M. tuberculosis, 4 of which caused cell growth
arrest when expressed in E. coli [54]. If the only MazG in M.
tuberculosis has a similar function as in E. coli and the A219E
mutation of H37Ra MazG does alter its function, the cellular
ppGpp level in H37Ra and the MazF (or other toxin/antitoxin
systems) mediated persistence might be altered as well. Therefore,
the MazG mutation might be critical for the original emergence of
H37Ra after aging. Further studies are needed to determine if this
mutated MazG provides an advantage for H37Ra to survive
during the aging-mediated cell lysis and to allow subsequent
accumulation of multiple mutations for better in vitro growth.
It has been reported that H37Ra lost the ability to synthesize
sulpholipids (SL), polyacyltrehalose (PAT) and phthiodiolone
dimycocerosate ester (PDIM) [26,56]. In accordance with the
known changes in cell wall lipids of H37Ra, we identified several
genes involved in cell wall lipid synthesis that are mutated in
H37Ra. PhoP is a positive transcriptional regulator that controls
the expression of many genes including pks2 and the msl3 gene
clusters involved in the biosynthesis of complex cell wall lipids such
as SL, PAT and diacyltrehalose [38,39]. Inactivation of PhoP
caused attenuated virulence in M. tuberculosis [37], loss of cell wall
lipids and cording property, and neutral red binding ability
[38,39]. We identified in H37Ra an S219L mutation in the DNA
binding a3 helix region of the PhoP protein. A recent study has
shown that although the PhoP S219L mutation is responsible for
loss of synthesis of some cell wall lipids and altered morphology of
H37Ra, it did not account for the loss of neutral red binding, the
production of virulence lipid PDIM and attenuated virulence since
complementation of H37Ra with phoP has failed to confer these
phenotypes [56].
Our study found other mutations besides PhoP that could be
responsible for the loss of virulence in H37Ra. The PDIM
synthesis defect in H37Ra and the loss of neutral red binding could
be due to a severe truncation in the nrp gene (non-ribosomal
peptide synthetase) and the two mutations in pks12 identified in
this study (Table 2, Table S3), which are expected to affect the
virulence of H37Ra. In M. bovis, the nrp (Mb0104) is the last gene
of an operon Mb0099-Mb0104 (ppe1-nrp) involved in the synthesis
of phthiocerol and PDIM [48,57]. Transposon insertion into
Mb0100 in M. bovis caused a polar effect on the expression of the
downstream genes including Mb0104, which led to altered
morphology and attenuation of virulence in guinea pigs [48],
suggesting nrp is an important virulence factor.
It is well known since 1950s that avirulent strain H37Ra has a
defect in anaerobic metabolism and survives much less well than
virulent H37Rv in vivo or under anaerobic conditions [10,11]. The
molecular basis for this phenomenon is unknown. We have shown
that H37Ra has a 58 bp repeat DNA insertion in the putative
promoter region of the lpdA-glpD2 operon, which could affect the
expression of both LpdA and GlpD2. The differential expression
phenotype of lpdA transcription revealed by our qRT-PCR
experiment indicated that the lpdA was probably an early response
gene involved in adaption to macrophage environment. The M.
tuberculosis LpdA (Rv3303c), despite its significant homology to other
LpdA enzymes, does not have lipoamide dehydrogenase activity but
instead has transhydrogenase activity and quinone reductase activity
that enables transfer of reducing power from the reduced pyridine
nucleotide pool to the electron transport chain [58], which could be
important for energy production under anaerobic conditions. LpdA
is a virulence factor involved in removing reactive oxygen species
released by the host cells and thus contributing to in vivo virulence
[59]. Although GlpD2 (Rv3302c) is annotated as glycerol-3-
phosphate dehydrogenase for aerobic respiration, its location in an
operon with anaerobic respiration enzyme LpdA suggests that
GlpD2 may be functionally more akin to anaerobic glycerol-3-
phosphate dehydrogenase (GlpA) involved in anaerobic respiration.
The 58 bp repeat DNA insertion in the putative promoter region of
the lpdA-glpD2 could affect the expression of lpdA and glpD2 and may
cause reduced survival of H37Ra under reduced oxygen tension in
host tissues.
Apart from lpdA, other genes with promoter region mutations
may also be involved in virulence attenuation since those genes in
H37Ra had different expression patterns compared to H37Rv
(Figure 2). Since SigC is a virulence factor in M. tuberculosis [31,32],
its altered expression caused by a promoter mutation may impact
its global regulatory effect and may be associated with virulence
attenuation in H37Ra. In addition, M. tuberculosis NrdEF2
complex forms the class Ib oxygen-dependent ribonucleotide
reductase, which catalyzes the reduction of ribonucleotides to
deoxyribonucleotides and is considered essential due to the failure
of obtaining null mutants in M. tuberculosis [41]. In this study, the
expression of the nrdHIEF2 operon was shown to be altered in
H37Ra compared to that in H37Rv (Figure 2). It is thus significant
to correlate this mutation with survival in vivo with respect to the
possible role of NrdEF2 in DNA repair, which is expected to occur
during exit from dormancy.
In summary, through successful combination of sequencing
genomics, comparative genomics and functional genomics strat-
egies, our study has provided, for the first time, a comprehensive
description of possible genetic variations, likely multiple mutations
in H37Ra, which may account for its attenuation of virulence and
various other phenotypic changes that are different from its
virulent counterpart H37Rv. Besides variations in the PE/PPE/
PE-PGRS genes, which have been shown to encode proteins with
diverse functions such as virulence, fibronectin binding, and cell
surface antigenic variations to evade the immune system
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proteins related to stress response (mazG), transcription activation
of lipid biosynthesis (phoP), amino acid biosynthesis (ilvD),
polyketide synthesis (pks12 and nrp) may also contribute to loss of
virulence in H37Ra. Our qRT-PCR experiments validated that
most genes with promoter mutations in H37Ra were up-regulated
in vitro but down-regulated in macrophages relative to H37Rv.
These promoter mutations may affect transcription of operons
encoding genes related to energy metabolism (lpdA-glpD2), cofactor
biosynthesis (pabB), nucleotide metabolism (nrdH/nrdE/nrdF2),
lipid metabolism (phoH2), protein degradation (ftsH), and sigma
factors (sigC), which may all contribute to the loss of virulence in
H37Ra (Figure 6). Further biochemical, molecular genetic and in
vivo studies are required to confirm and assess the relative
importance of these mutations in causing the attenuation of
virulence in H37Ra. Such studies will not only improve our
understanding of mechanisms of pathogenesis of M. tuberculosis but
also facilitate design of new vaccines and new therapeutic agents
based on the identified virulence-associated mutations.
Materials and Methods
Bacterial strain and genome sequencing
M. tuberculosis strain H37Ra (ATCC25177) was freshly obtained
from American Type Culture specifically for the purpose of
genome sequencing in this study. The H37Ra was grown in
Middlebrook 7H9 liquid medium with ADC (albumin-dextrose-
catalase) supplement to late log phase for preparation of high-
molecular weight genomic DNA as described [62]. Shotgun
sequencing approach was performed employing three independent
genomic libraries with average DNA fragments of 2–3 kb, 6–8 kb
and 8–10 kb, respectively, constructed in the pSMART-LC vector
(Lucigen Corporation). A total of 44,366 reads, or about 7 times
coverage of the genome, were separately generated from the
libraries by sequencing both ends of the clones. Arachne [63] and
Phrap (www.phrap.org) were used for sequence assembly.
Sequence gaps were filled in by first determining the order of
supercontigs using multiplex PCR [64] and then sequencing the
PCR products via primer walking or shotgun sequencing. The
H37Rv strain used in this study for resequencing to resolve the
discrepancies in the published H37Rv genome sequence [1] was
obtained from Johns Hopkins for TB Research (E. Nuermberger,
J. Grosset, W. Bishai, who obtained this strain in 1998 from Frank
Collins then at Trudeau Institute where H37Rv was originally
isolated by William Skeenken in 1935). This H37Rv strain has
been maintained in mice to prevent loss of virulence and is not
subjected to repeated in vitro cultivation.
Sequence annotation and bioinformatic analysis
CDSs were identified by ZCURVE 1.0 [65]. Transfer RNA
genes were predicted by tRNAscan-SE [66]. Functional annota-
tion of CDSs was performed through comparisons to public and
in-house databases using BLASTP, followed by manual curation.
Comparative genome analysis was performed by using the Artemis
Comparison Tool (ACT; www.sanger.ac.uk_Software). Promoter
region was analyzed by Neural Network Promoter Prediction
(http://www.fruitfly.org/seq_tools/ promoter.html). The atlas of
genome is drawn using GenomeViz1.1 [67].
Quantitative RT-PCR
M. tuberculosis H37Rv and H37Ra were grown in Middlebrook
7H9 broth with albumin-dextrose-catalase supplement (Becton
Dickinson) to log phase. The THP-1 macrophage cell culture was
performed as previously described [68]. THP-1 cells were infected
with exponential bacterial suspensions of H37Rv and H37Ra at
multiplicity of infection of 10:1. After incubating the mixture for
1.5 h at 37uC extracellular bacteria and non-adhered cells were
removed by washing with RPMI medium. RNA was extracted
from H37Rv and H37Ra in vitro or post macrophage infection.
Random primers were used to synthesize first strand cDNA using
the SuperScript II RT system (Invitrogen). Real-time quantitative
PCR reactions were performed using the SYBR Green PCR Kit
(TOYOBO) following the manufacturer’s protocol. The reactions
were carried out in a 96-well reaction plate and reporter
fluorescence was measured on an iCycler real-time PCR system
(Bio-Rad) using the following thermal cycler conditions: denatur-
Figure 6. Schematic Diagram of Major H37Ra Genes with Functions Affected by Mutations. The genes in blue and in green indicate
variations that occurred in coding sequences and in promoter regions, respectively.
doi:10.1371/journal.pone.0002375.g006
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for 30 s, 65uC for 20 s, 72uC for 30 s; final extension, 1 cycle,
72uC for 5 min. Relative transcript levels of the target genes were
calculated by normalizing the levels of RNA of target genes with
the level of 16 S rRNA gene or sigA expression in the same sample.
Changes in target gene’s mRNA levels between H37Ra and
H37Rv were illustrated by the ratio of relative transcription levels
of H37Ra compared to H37Rv.
Statistical analysis
The RT-PCR data of the transcription levels of selected genes
with promoter mutations were subjected to statistical analysis.
Significance was defined according to p-values calculated from
Student t-test analysis of DCt values of the selected genes between
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